Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology

Simple Summary Fusion imaging depicts an innovative technique by which previously performed computed tomography/magnetic resonance imaging can be integrated and reconstructed with advanced contrast-enhanced ultrasound using modern ultrasound devices in a real-time manner. Fusion imaging allows for complementing strengths and reducing restrictions of the combined imaging modalities. The visualization of parenchymal and tumoral microperfusion by contrast-enhanced ultrasound can be dynamically fused and assessed with images from previous cross-sectional studies and may help to decipher underlying entities of indeterminate lesions or validate suspicious morphology. The findings from our study demonstrate the benefits of fusion imaging for evaluating focal hepatic and renal lesions. The excellent safety profile, accessibility, repeatability and cost-effectiveness are advantages of fusion imaging which make it a powerful diagnostic tool for the modern radiologist. Abstract Fusion imaging depicts an innovative technique that facilitates combining assets and reducing restrictions of advanced ultrasound and cross-sectional imaging. The purpose of the present retrospective study was to evaluate the role of fusion imaging for assessing hepatic and renal lesions. Between 02/2011–08/2020, 92 patients in total were included in the study, of which 32 patients had hepatic lesions, 60 patients had renal lesions. Fusion imaging was technically successful in all patients. No adverse side effects upon intravenous (i.v.) application of SonoVue® (Bracco, Milan, Italy) were registered. Fusion imaging could clarify all 11 (100%) initially as indeterminate described hepatic lesions by computed tomography/magnetic resonance imaging (CT/MRI). Moreover, 5/14 (36%) initially suspicious hepatic lesions could be validated by fusion imaging, whereas in 8/14 (57%), malignant morphology was disproved. Moreover, fusion imaging allowed for the clarification of 29/30 (97%) renal lesions initially characterized as suspicious by CT/MRI, of which 19/30 (63%) underwent renal surgery, histopathology revealed malignancy in 16/19 (84%), and benignity in 3/19 (16%). Indeterminate findings could be elucidated by fusion imaging in 20/20 (100%) renal lesions. Its accessibility and repeatability, even during pregnancy and in childhood, its cost-effectiveness, and its excellent safety profile, make fusion imaging a promising instrument for the thorough evaluation of hepatic and renal lesions in the future.

[1]  D. Clevert,et al.  Safe and pivotal approaches using contrast-enhanced ultrasound for the diagnostic workup of non-obstetric conditions during pregnancy, a single-center experience , 2020, Archives of Gynecology and Obstetrics.

[2]  Hui-Xiong Xu,et al.  Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. , 2017, The British journal of radiology.

[3]  M. Lee,et al.  Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US , 2014, Clinical and molecular hepatology.

[4]  Puylaert Jb.  Ultrasound of acute GI tract conditions. , 2001 .

[5]  Yili Liu,et al.  The Value of Contrast-Enhanced Ultrasonography and Contrast-Enhanced CT in the Diagnosis of Malignant Renal Cystic Lesions: A Meta-Analysis , 2016, PloS one.

[6]  A. Finelli,et al.  Landmarks in the diagnosis and treatment of renal cell carcinoma , 2014, Nature Reviews Urology.

[7]  A. Zaheer,et al.  ACR Appropriateness Criteria® Right Upper Quadrant Pain. , 2019, Journal of the American College of Radiology : JACR.

[8]  M. Bosniak.  The Bosniak renal cyst classification: 25 years later. , 2012, Radiology.

[9]  T. Helbich,et al.  Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis , 2016, European Radiology.

[10]  C. Dietrich,et al.  Gastrointestinal Ultrasound (GIUS) in Intestinal Emergencies – An EFSUMB Position Paper , 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

[11]  G. Israel,et al.  Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. , 2004, Radiology.

[12]  Kathryn J Fowler,et al.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. , 2018, Radiology.

[13]  E. Jung,et al.  Contrast-enhanced ultrasound (CEUS) of cystic renal lesions in comparison to CT and MRI in a multicenter setting. , 2020, Clinical hemorheology and microcirculation.

[14]  C. Sirlin,et al.  Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis , 2018, Hepatology.

[15]  D. Clevert,et al.  Comparison of Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound as Diagnostic Options for Unclear Cystic Renal Lesions: A Cost-Effectiveness Analysis , 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

[16]  James A Brink,et al.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. , 2010, Journal of the American College of Radiology : JACR.

[17]  M. Reiser,et al.  Feasability of contrast-enhanced ultrasound with image fusion of CEUS and MS-CT for endovascular grafting in infrarenal abdominal aortic aneurysm in a single patient. , 2016, Clinical hemorheology and microcirculation.

[18]  Lemin Tang,et al.  Comparison of contrast-enhanced ultrasound with MRI in the diagnosis of complex cystic renal masses: a meta-analysis , 2018, Acta radiologica.

[19]  T. Klatte,et al.  Epidemiology and screening for renal cancer , 2018, World Journal of Urology.

[20]  M. Reiser,et al.  MRI and contrast enhanced ultrasound (CEUS) image fusion of renal lesions. , 2017, Clinical hemorheology and microcirculation.

[21]  M. Y. Park,et al.  MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm. , 2017, AJR. American journal of roentgenology.

[22]  Fernando Calamante,et al.  Gadolinium deposition in the brain: summary of evidence and recommendations , 2017, The Lancet Neurology.

[23]  N. Rofsky,et al.  MR classification of renal masses with pathologic correlation , 2008, European Radiology.

[24]  D. Clevert,et al.  Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis , 2018, European Radiology.

[25]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[26]  D. Clevert,et al.  Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing renal oncocytoma , 2020, Scandinavian journal of urology.

[27]  M. Bosniak.  Problems in the radiologic diagnosis of renal parenchymal tumors. , 1993, The Urologic clinics of North America.

[28]  J. Marrero,et al.  Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis , 2009, Alimentary pharmacology & therapeutics.

[29]  P M Paprottka,et al.  Image fusion in the management of thermal tumor ablation of the liver. , 2012, Clinical hemorheology and microcirculation.

[30]  C. Dietrich,et al.  EFSUMB Position Paper: Recommendations for Gastrointestinal Ultrasound (GIUS) in Acute Appendicitis and Diverticulitis , 2019, Ultraschall in der Medizin - European Journal of Ultrasound.

[31]  B. K. Park,et al.  Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. , 2007, European journal of radiology.

[32]  Dean Y. Huang,et al.  Contrast enhanced ultrasound (CEUS) in Pregnancy: Is this the last frontier for microbubbles? , 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

[33]  M. C. Chammas,et al.  Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS , 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

[34]  European Society of Radiology.  Abdominal applications of ultrasound fusion imaging technique: liver, kidney, and pancreas , 2019 .

[35]  L. Bolondi,et al.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. , 2006, Ultrasound in medicine & biology.

[36]  M. Bosniak,et al.  The current radiological approach to renal cysts. , 1986, Radiology.

[37]  D. Clevert,et al.  Single-Center Study: Evaluating the Diagnostic Performance and Safety of Contrast-Enhanced Ultrasound (CEUS) in Pregnant Women to Assess Hepatic Lesions , 2019, Ultraschall in der Medizin - European Journal of Ultrasound.

[38]  D A Clevert,et al.  Multimodality imaging using ultrasound image fusion in renal lesions. , 2012, Clinical hemorheology and microcirculation.

[39]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[40]  Hui-Xiong Xu,et al.  Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. , 2016, The British journal of radiology.

[41]  G. Berg,et al.  The role of contrast-enhanced ultrasound in the classification of CT-indeterminate renal lesions , 2016, Scandinavian journal of urology.

[42]  M. Beer,et al.  Ultrasound 2020 - Diagnostics & Therapy: On the Way to Multimodal Ultrasound: Contrast-Enhanced Ultrasound (CEUS), Microvascular Doppler Techniques, Fusion Imaging, Sonoelastography, Interventional Sonography. , 2020, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[43]  Richard Wakeford,et al.  Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. , 2009, Radiology.

[44]  D. Clevert,et al.  Multislice computed tomography/contrast-enhanced ultrasound image fusion as a tool for evaluating unclear renal cysts , 2018, Ultrasonography.

[45]  M. Friedrich-Rust,et al.  Tumor-Specific Vascularization Pattern of Liver Metastasis, Hepatocellular Carcinoma, Hemangioma and Focal Nodular Hyperplasia in the Differential Diagnosis of 1349 Liver Lesions in Contrast-Enhanced Ultrasound (CEUS) , 2009, Ultraschall in der Medizin.

[46]  M. Friedrich-Rust,et al.  Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Focal Liver Lesions – Prospective Comparison in Clinical Practice: CEUS vs. CT (DEGUM Multicenter Trial) Parts of this Manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos , 2009, Ultraschall in der Medizin.

[47]  Kevin J Chang,et al.  ACR Appropriateness Criteria® Left Lower Quadrant Pain-Suspected Diverticulitis. , 2019, Journal of the American College of Radiology : JACR.

[48]  M. Reiser,et al.  Contrast-Enhanced Ultrasound (CEUS) of the Kidneys by Using the Bosniak Classification , 2016, Ultraschall in der Medizin - European Journal of Ultrasound.

[49]  C. Ewertsen,et al.  Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI. , 2011, Ultraschall in der Medizin.

[50]  M. Kudo,et al.  Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update , 2017, Hepatology International.

[51]  R. Zheng,et al.  Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients , 2017, BMC Cancer.

[52]  M. Lee,et al.  Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. , 2013, AJR. American journal of roentgenology.

[53]  D. Strobel,et al.  A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA , 2016, Ultraschall in der Medizin.

[54]  D. Clevert,et al.  Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients , 2020, The Journal of international medical research.

[55]  Tae Hyun Kim,et al.  2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma , 2019, Gut and liver.

[56]  M. Staehler,et al.  Contrast-Enhanced Ultrasound (CEUS) for Follow-Up of Bosniak 2F Complex Renal Cystic Lesions—A 12-Year Retrospective Study in a Specialized European Center , 2020, Cancers.

[57]  K. Nouso,et al.  Cost‐effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast‐enhanced ultrasonography , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[58]  Kevin J Chang,et al.  ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain. , 2018, Journal of the American College of Radiology : JACR.

[59]  Y. Chawla,et al.  Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma. , 2017, Journal of clinical and experimental hepatology.

[60]  E M Jung,et al.  New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. , 2009, Clinical hemorheology and microcirculation.

[61]  D Becker,et al.  Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). , 2008, Ultraschall in der Medizin.

[62]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[63]  Ivan Pedrosa,et al.  Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. , 2019, Radiology.

[64]  M. Sherman.  Surveillance for hepatocellular carcinoma. , 2014, Best practice & research. Clinical gastroenterology.

[65]  D. Clevert,et al.  Comparison of computed tomography (CT), magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) in the evaluation of unclear renal lesions Vergleich von Computertomografie (CT), Magnetresonanztomografie (MRT) und kontrastverstärktem Ultraschall (CEUS) bei der Beurteilung unklarer Ni , 2020, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[66]  L. Kai,et al.  A Feasibility Study for Determining Ablative Margin with 3D-CEUS-CT/MR Image Fusion after Radiofrequency Ablation of Hepatocellular Carcinoma , 2012, Ultraschall in der Medizin.

[67]  M. Reiser,et al.  Improving the follow up after EVAR by using ultrasound image fusion of CEUS and MS-CT. , 2011, Clinical hemorheology and microcirculation.